The global HIV antivirals market is experiencing remarkable growth, with sales achieving USD 30.6 billion in 2022. Fueled by increasing global awareness and significant advancements in pharmaceutical research, the market is projected to expand to USD 47.0 billion by 2032, driven by a steady Compound Annual Growth Rate (CAGR) of 4.4%.
This extraordinary growth underscores the strides being made in HIV/AIDS treatment, reflecting the dedication of the healthcare community to advancing therapeutic solutions for a condition that remains a significant public health challenge worldwide.
Transforming HIV into a Manageable Condition
Advancements in HIV diagnosis, treatment, and prevention have been pivotal in transforming the infection into a manageable chronic health condition akin to cancer and tuberculosis. These developments empower individuals living with HIV to lead fulfilling and healthy lives. The increasing demand for HIV antivirals is a testament to the global commitment to improving the quality of life for those affected and reducing stigma associated with the condition.
Global Awareness Driving Market Growth
Rising awareness of HIV causes, symptoms, and treatment options continues to fuel market expansion. Educational initiatives, such as those by the U.S. Department of Health & Human Services, play a critical role in driving public engagement. Programs like the National Institute of Allergy and Infectious Diseases (NIAID)’s observance of HIV Vaccine Awareness Day on May 18th highlight the collaborative efforts of community members, healthcare professionals, and scientists working tirelessly to develop preventive HIV vaccines.
Future Outlook: A Promising Path Forward
As global health initiatives prioritize innovation and awareness, the future of the HIV antivirals market appears increasingly optimistic. Sustained efforts in research and development, coupled with enhanced public health education, are set to further accelerate market growth. These advancements not only bolster healthcare outcomes but also contribute to broader global health consciousness.
The expansion of the HIV antivirals market reflects a commitment to combating one of the world’s most pressing health challenges. As the industry continues to innovate, the global community remains steadfast in its mission to enhance lives and foster a healthier, stigma-free world for those affected by HIV/AIDS.
Key Takeaways from Market Study:
- Because of their ability to increase adherence to an HIV treatment regimen, fixed-dose combinations (FDCs) owned more than 83.2% of the market value in 2021.
- Hospital pharmacies are the dominant sales channel for HIV antivirals, accounting for over 53.4% of the market in 2021, and are expected to increase at a CAGR of 4.5% over the next decade.
- In 2021, the United States dominated the North American HIV antivirals market, with a total market share of around 96.8%.
- Because of the increasing number of HIV patients in the country, India is likely to lead the growth in the South Asian market.
“With increasing awareness among the people about HIV causes and symptoms, the HIV antivirals market is set witness positive growth during the forecast period. Hence, key players are developing anti-HIC drugs vaccines to increase their revenue,” says an analyst of Future Market Insights.
Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!
Competitive Landscape:
Key players in the HIV antivirals market are focusing on collaborations and securing FDA approvals as primary strategies to expand their business.
These strategies will help market players like Theratechnologies and AbbVie enhance their product portfolios and increase market penetration, thereby boosting their revenue share in the global market.
For example:
- In December 2021, Theratechnologies submitted a supplemental biologics license application to the FDA to advance the development of IV Push Trogarzo® for patients living with HIV.
- In March 2020, AbbVie announced a partnership with international authorities to test the efficacy of HIV medicines in treating COVID-19.
Key Companies Profiled:
- ViiV Healthcare
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Johnson & Johnson
- Genetech, Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie
- Cipla
- Pfizer Inc.
- Mylan N.V.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Macleods Pharmaceuticals Ltd
- Emcure Pharmaceuticals Limited
- Aspen Pharmacare Limited
- Lupin Ltd.
- Sun Pharmaceutical Industries Ltd.
- Theratechnologies Inc.
- Strides Arcolab Limited
- Hetero labs limited
- Laurus Laboratories Ltd
Key Market Segments Covered in HIV Antivirals Market Research:
By Product:
- Fixed Dose Combinations (FDCs)
- Integrase Strand Transfer Inhibitors (INSTIs)
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Entry Inhibitors – CCR5 co-receptor antagonist
- Protease Inhibitors (PIs)
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube